Skip to content
REVAL Health®

Usage Guide

A dual GLP-1 and GIP receptor agonist studied for metabolic health and weight management.

Supports Weight Management
Helps Regulate Appetite
Involved in Metabolic Regulation

How It Works

Tirzepatide activates GLP-1 and GIP receptors involved in appetite, food intake and metabolic regulation.

Concept illustration of GLP-1 and GIP receptors

How to Use

1

Prepare

Wash hands and gather your prescribed supplies.

2

Clean

Wipe the vial stopper with an alcohol pad and let it dry.

3

Draw Dose

Only draw the dose directed by your clinician, using the correct product instructions.

4

Inject

Follow your prescribed product’s approved instructions for subcutaneous injection.

5

Dispose

Place used needles and syringes in an approved sharps container.

General handling overview only. Use the exact preparation, dose and technique specified for your prescribed, approved product.

Injection Areas

Illustrative abdomen, thigh and upper arm injection areas

Illustrative anatomy. Follow your prescribed medication’s directions and rotate areas as instructed.

Storage & Handling

Follow Verified Refrigeration Instructions

FDA-approved tirzepatide products commonly specify 2–8°C (36–46°F); confirm rules for your exact product.

Do Not Freeze

Do not use a medication that its approved labeling says must be discarded after freezing.

Protect From Light

Keep in the original packaging where required by the validated label.

Important: Storage temperatures, shelf life and any reconstitution instructions for ALUNEVIA have not been validated here. Do not apply another manufacturer’s instructions to a different formulation.